Letrozole is a widely used medication for treating hormone receptor-positive breast cancer in postmenopausal women. As an aromatase inhibitor, it works by reducing estrogen production, which helps slow or stop the growth of hormone-sensitive tumors. It is often prescribed as a first-line treatment for advanced breast cancer and as an adjuvant therapy to prevent cancer recurrence.
In addition to its cancer-fighting properties, Letrozole is sometimes used off-label to treat ovulation disorders in women struggling with infertility. By lowering estrogen levels, it stimulates ovulation, making it a preferred choice for fertility treatments.
A reputable Letrozole manufacturer follows strict GMP, US FDA, and EMA guidelines to ensure high-quality production. Quality control, purity, and efficacy are crucial in manufacturing Letrozole to provide safe and effective treatment options.
Reliable Letrozole manufacturers play a key role in making this essential medication accessible worldwide, supporting cancer patients and those undergoing fertility treatments.